Association Analysis of TEC Polymorphisms with Aspirin-Exacerbated Respiratory Disease in a Korean Population

The tyrosine-protein kinase Tec (TEC) is a member of non-receptor tyrosine kinases and has critical roles in cell signaling transmission, calcium mobilization, gene expression, and transformation. TEC is also involved in various immune responses, such as mast cell activation. Therefore, we hypothesized that TEC polymorphisms might be involved in aspirin-exacerbated respiratory disease (AERD) pathogenesis. We genotyped 38 TEC single nucleotide polymorphisms in a total of 592 subjects, which comprised 163 AERD cases and 429 aspirin-tolerant asthma controls. Logistic regression analysis was performed to examine the associations between TEC polymorphisms and the risk of AERD in a Korean population. The results revealed that TEC polymorphisms and major haplotypes were not associated with the risk of AERD. In another regression analysis for the fall rate of forced expiratory volume in 1 second (FEV1) by aspirin provocation, two variations (rs7664091 and rs12500534) and one haplotype (TEC_BL2_ht4) showed nominal associations with FEV1 decline (p = 0.03-0.04). However, the association signals were not retained after performing corrections for multiple testing. Despite TEC playing an important role in immune responses, the results from the present study suggest that TEC polymorphisms do not affect AERD susceptibility. Findings from the present study might contribute to the genetic etiology of AERD pathogenesis.

[1]  W. Ellmeier,et al.  The protein tyrosine kinase Tec regulates mast cell function , 2009, European journal of immunology.

[2]  K. Min,et al.  Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. , 2009, Respiratory medicine.

[3]  Seung-Hyun Kim,et al.  What do we know about the genetics of aspirin intolerance? , 2008, Journal of clinical pharmacy and therapeutics.

[4]  G. Hur,et al.  CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. , 2007, Pharmacogenomics.

[5]  Wei-Chiao Chang,et al.  Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c‐fos through ERK‐dependent and independent pathways in mast cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[7]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[8]  H. Kung,et al.  Signaling network of the Btk family kinases , 2000, Oncogene.

[9]  A. Szczeklik,et al.  Natural history of aspirin‐induced asthma , 2000 .

[10]  J. Kaprio,et al.  Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. , 1999, International journal of epidemiology.

[11]  Hae‐Sim Park,et al.  Early and late onset asthmatic responses following lysine‐aspirin inhalation in aspirin‐sensitive asthmatic patients , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  Y. Yazaki,et al.  Molecular cloning and analysis of the human Tec protein-tyrosine kinase. , 1994, Leukemia.

[13]  S. Desiderio Becoming B cells , 1993, Nature.

[14]  P. Hedrick,et al.  Gametic disequilibrium measures: proceed with caution. , 1987, Genetics.

[15]  E. Nizankowska,et al.  Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. , 2000, The European respiratory journal.

[16]  S. Desiderio Human genetics. Becoming B cells. , 1993, Nature.